61%
Finnrick rating
#255 of 283 ranked vendors
16 of 30 classifiable tests passed
methodology · Purity focus
Finnrick analysis

Injectify's purity-focused record is strongest for Semaglutide and Melanotan II, with verified identity, high purity, and near-label fill across their tested vials. Results are dispersed: Retatrutide and Ipamorelin show recent purity slips, while CJC-1295 and BPC-157 carry repeated purity or identity failures; several signals still rest on single-batch runs.

methodology →
vendor intelligence report
Vendor Intelligence Report: Injectify

Injectify's own policies name a New York LLC, but registry and principal trails remain unresolved. The report follows the shifted closure sale, split US/Canada storefronts, affiliate-code ecosystem, crypto-payment indicators, and peer regulatory context.

25 pages8 risk factors assessed2 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
Retatrutide
$12.40
78%
4
2
Semaglutide
$20.60
76%
4
3
Melanotan II
$3.70
73%
4
4
Ipamorelin
$6.14
70%
4
5
BPC-157
$10.00
43%
7
6
CJC-1295
$22.00
16%
7
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%22 Apr 2025: 16%22 Apr 2025: 27%22 Apr 2025: 26%22 Apr 2025: 25%5 May 2025: 24%5 May 2025: 22%5 May 2025: 20%5 May 2025: 20%16 May 2025: 38%16 May 2025: 47%16 May 2025: 50%16 May 2025: 51%16 May 2025: 52%16 May 2025: 52%16 May 2025: 52%16 May 2025: 53%16 May 2025: 52%16 May 2025: 53%16 May 2025: 53%16 May 2025: 53%13 Jun 2025: 53%13 Jun 2025: 54%14 Jun 2025: 54%14 Jun 2025: 54%16 Jun 2025: 54%22 Jul 2025: 54%23 Jul 2025: 53%25 Jul 2025: 53%5 Sept 2025: 52%8 May 2026: 52%1 Aug 2026: current 61%16%61%Apr 25Aug 26
Injectify test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
8 May 2026Pass
Melanotan II
lab nameView COA
5 Sep 2025Fail
Ipamorelin
lab nameView COA
25 Jul 2025Fail
BPC-157
lab nameView COA
23 Jul 2025Fail
Retatrutide
lab nameView COA
22 Jul 2025Pass
Semaglutide
lab nameView COA
16 Jun 2025Fail
CJC-1295 (DAC)
lab nameView COA
14 Jun 2025Pass
Semaglutide
lab nameView COA
14 Jun 2025Pass
Melanotan II
lab nameView COA
13 Jun 2025Pass
Ipamorelin
lab nameView COA
13 Jun 2025Pass
Retatrutide
lab nameView COA
1-10 of 30

About Injectify test results from Finnrick

Injectify is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 6 peptides and 30 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Injectify peptides in this dataset are Melanotan II (4 tests) and CJC-1295 (7 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 30 recent tests.

Corrections
No corrections.